Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.70 EUR
Change Today +0.066 / 2.51%
Volume 0.0
S7Y On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 2:19 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

solazyme inc (S7Y) Snapshot

Open
€2.70
Previous Close
€2.63
Day High
€2.75
Day Low
€2.70
52 Week High
07/3/14 - €8.68
52 Week Low
02/26/15 - €1.49
Market Cap
216.0M
Average Volume 10 Days
213.0
EPS TTM
--
Shares Outstanding
80.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SOLAZYME INC (S7Y)

solazyme inc (S7Y) Related Businessweek News

View More BusinessWeek News

solazyme inc (S7Y) Details

Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blendstocks for marine, motor vehicle, and jet fuels, as well as replacements for petrochemicals, oleochemicals, and functional fluids. It also provides fuels, including SoladieselBD and SoladieselRD for on-road applications; ultra-low sulfur diesel; and Solajet for aviation use. In addition, the company offers microalgae-based food ingredients consisting of Tailored oils and powdered oils; and powdered ingredients comprising AlgaVia whole algal flour, AlgaVia whole algal protein, AlgaVia lipid powder, and encapsulated oils. Additionally, it provides skin and personal care products under the Algenist brand name, which include concentrated reconstructing serum, an anti-aging serum; complete eye renewal balm; firming and lifting cream, an anti-aging moisturizing cream; advanced anti-aging repairing oil, a face oil formulation; and genius cream. The company was incorporated in 2003 and is headquartered in South San Francisco, California.

266 Employees
Last Reported Date: 03/6/15
Founded in 2003

solazyme inc (S7Y) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $560.0K
Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $410.4K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $335.0K
Chief Technology Officer
Total Annual Compensation: $370.8K
Strategic Advisor
Total Annual Compensation: $378.8K
Compensation as of Fiscal Year 2014.

solazyme inc (S7Y) Key Developments

Labaton Sucharow LLP Files Class Action Lawsuit Against Solazyme, Inc

Labaton Sucharow LLP filed a securities class action lawsuit in the U.S. District Court for the Northern District of California. The lawsuit was filed on behalf of all persons or entities who, between February 27, 2014 and November 5, 2014, inclusive, purchased or otherwise acquired the publicly traded securities of Solazyme, Inc., including certain securities issued by Solazyme pursuant and/or traceable to either of two registered public offerings on or about March 27, 2014. The complaint charges Solazyme and certain of its officers and directors with violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder. The complaint alleges that certain Defendants made false and misleading statements and concealed material information relating to the construction progress, development, and expected production capacity of the company’s renewable oils production facility located in Moema, Brazil. Specifically, Defendants caused Solazyme securities to trade at artificially inflated prices by improperly concealing ongoing construction delays due to insufficient access to electricity and steam utility services. These challenges prohibited the Moema Facility from scaling its capacity production as projected. Additionally, the complaint alleges that Solazyme, certain of its officers and directors, and the underwriters of the Offerings violated Sections 11, 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that certain Defendants made false and misleading statements and failed to disclose material adverse information in offering documents filed with the U.S. Securities and Exchange Commission in connection with the issuance of (i) approximately $149.5 million in convertible notes on or about March 27, 2014, and (ii) 5.75 million shares of common stock on the same day at $11.00 per share for aggregate gross proceeds of approximately $63.25 million.

Natura Cosméticos S.A. and Solazyme, Inc. Announce Sales Agreement for Microalgae Oil

Natura Cosméticos S.A. and Solazyme, Inc. announced that after successfully completing testing and product validation phases over the past year using Solazyme's oils, Natura is purchasing Solazyme's high-performance AlgaP Microalgae Oil, which will be incorporated into Natura's multiple product lines. Solazyme's microalgae oils are produced in a matter of days using a fermentation process designed to produce oils of the utmost purity, performance and sustainability. Some of the benefits of using AlgaP oils for skin care are higher hydration levels, a silky but not greasy skin feel, mildness on the skin, neutral color and odor, and improved shelf life.

Solazyme, Inc. Presents at Cowen and Company 43rd Annual Technology, Media & Telecom Conference 2015, May-28-2015

Solazyme, Inc. Presents at Cowen and Company 43rd Annual Technology, Media & Telecom Conference 2015, May-28-2015 . Venue: The New York Palace Hotel, 455 Madison Avenue, New York, NY 10022, United States. Speakers: Tyler W. Painter, Chief Financial Officer and Chief Operating Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
S7Y:GR €2.70 EUR +0.066

S7Y Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amyris Inc $1.75 USD -0.04
Gevo Inc $3.19 USD -0.07
Wessanen €7.98 EUR 0.00
Pacific Ethanol Inc $10.06 USD +0.23
Renewable Energy Group Inc $11.84 USD +0.11
View Industry Companies
 

Industry Analysis

S7Y

Industry Average

Valuation S7Y Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.1x
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit www.solazyme.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.